# data[].attributes.headline
DNA Sequencing Cancer Treatment - Paradigm Diagnostics, Inc.

# data[].attributes.subject
DNA Sequencing Cancer Treatment - Paradigm Diagnostics, Inc.

# data[].attributes.body
Paradigm Diagnostics, Inc. is an expert in the DNA test for cancer genes. DNA testing for cancer treatment offers mRNA and miRNA analysis for complete diagnostics of patient’s disease. Connect with them today!

# data[].attributes.attachment_link.readable_text
Next-generation cancer diagnostics.

Order Now

About PCDx

The PCDx test provides patients and physicians with a blueprint of the underlying mechanisms of a patient's disease, potential treatment approaches, and comprehensive inventory of relevant clinical trials.

Continue reading

Targeted diagnostics

The PCDx test identifies actionable classes of genomic alterations in hundreds of cancer-related genes, including the following.

Order PCDx

Fusions / Isoforms

Fusions and isoforms are rearrangements of genes or the exons within genes that result in abnormal gene expression or function. These alterations can have significant impact on therapy, particularly in non-small cell lung cancers. PCDx precisely identifies the exact breakpoints with single-base resolution.

Paradigm Diagnostics, Inc., 445 N. 5th Street, Suite 300 85004 | 602.850.7000 | Contact Us

Sign up for updates:

# data[].attributes.attachment_link.description
Order Now The PCDx test provides patients and physicians with a blueprint of the underlying mechanisms of a patient's disease, potential treatment approaches, and comprehensive inventory of relevant clinical trials. Continue reading The PCDx test identifies actionable classes of genomic alterations in hundreds of cancer-related genes, including the following.

# data[].attributes.headline
Advanced Cancer Treatment- Paradigm Diagnostics, Inc.

# data[].attributes.subject
Advanced Cancer Treatment- Paradigm Diagnostics, Inc.

# data[].attributes.body
Paradigm Diagnostics, Inc. offers advanced cancer treatment test for the comprehensive analysis of DNA, mRNA, and miRNA. They also offerclinical translational medicine for cancer treatment. Visit website today!

# data[].attributes.attachment_link.readable_text
A team dedicated to advancing cancer treatment

BioPharma Services

Paradigm's BioPharma Services team has a successful history of partnering with pharmaceutical, biotech, and research institutions to provide state-of-the-art comprehensive analyses of DNA, mRNA, and miRNA.

Continue reading

Paradigm offers the latest molecular techniques, high-throughput sequencing, and translational biobanking expertise. This is combined with deep knowledge of the oncology market and successfully introducing molecular testing into patient care to assist clinical trials for our pharmaceutical, hospital, and research partners and to better individualize therapy and advance patient care.

Paradigm's BioPharma Services team has a successful history of partnering with pharmaceutical, biotech, and research institutions to provide state-of- the-art comprehensive analyses of DNA, mRNA, and miRNA (collaborators). Our logistics team has core competencies in high throughput complex projects for advanced clinical trials and research studies.

Core services include:

Personalized Clinical Trial Assays

Molecular Services

Biorepository consultation

Biostorage facility

Nucleic Acid Isolation

Biospecimen collection, storage,
processing, and analysis

PCDx Cancer Diagnostic Translational
Collaboration: Clinical Trial Enrichment

Contact us

Molecular Services

Next-generation sequencing: Next-Generation Sequencing for DNA, mRNA expression, DNA CNV, chromosomal deletions, translocations, inversions. Paradigm routinely provides profiling for industry and academic researchers to help provide a molecular context to their clinical trial data.

Immunohistochemistry (IHC): The Paradigm team has extensive experience with both standard and new immunohistochemistry lab technologies with deep expertise in developing and validating new assays. All work is performed in a CLIA/CAP facility with quick turnaround and to the highest standards of quality. Digital imaging is available in addition to automated and semi-automated protocols.

Biorepository consultation

Paradigm, in collaboration with the International Genomics Consortium, offers over 100 years of combined expertise and resources to assist industry, researchers, and academic medical centers to:

Optimally procure specimens

Preserve targets

Strategize on the best detection methods to maximize outcome

Assist in providing leading genomic and proteomic analysis to complement and maximize clinical findings.

Paradigm Diagnostics, Inc., 445 N. 5th Street, Suite 300 85004 | 602.850.7000 | Contact Us

Sign up for updates:

# data[].attributes.attachment_link.description
A team dedicated to advancing cancer treatment Paradigm's BioPharma Services team has a successful history of partnering with pharmaceutical, biotech, and research institutions to provide state-of-the-art comprehensive analyses of DNA, mRNA, and miRNA. Continue reading Paradigm offers the latest molecular techniques, high-throughput sequencing, and translational biobanking expertise.

# data[].attributes.body
Paradigm Diagnostics, Inc. is a cancer diagnostics company. It provides next-generation sequencing test for cancer diagnostics. Their Paradigm Cancer Diagnostic (PCDx) is a comprehensive test available today.

# data[].attributes.attachment_link.title
Personalized Cancer Diagnostics | Paradigm

# data[].attributes.attachment_link.description
PCDx is the most sophisticated & comprehensive next-generation cancer diagnostic test available today.